You just read:

Guardant Health Announces Collaboration With Principia Biopharma To Use Guardant360® for Monitoring Patient Response and Tumor Evolution in FGFR Inhibitor Trials

News provided by

Guardant Health

Mar 29, 2016, 09:00 ET